Saturday, July 11, 2026

biotech · ALK-positive Non-small Cell Lung Cancer · Biliary Tract Carcinoma

Zelgen Biopharmaceuticals

Zelgen Biopharmaceuticals trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Kunshan, CN HQ
8 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Kunshan, CN
Employees
8
Programs
3
Drugs
7
Patents
0
Intelligence · Clinical Trials

Zelgen Biopharmaceuticals clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Zelgen Biopharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Zelgen Biopharmaceuticals trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Zelgen Biopharmaceuticals.

  1. ZG0895 Hydrochloride for Injection — Phase 1

    Clinical update
  2. Alkotinib Capsules — Phase 2

    Clinical update
  3. ZG005 — Phase 2

    Clinical update

Trial registry

3 studies